PRECAUTIONS Lorazepam 0.5 mg
Lorazepam 0.5 mg is the additive central-nervous-system effects of other drugs, such as phenothiazines, narcotic analgesics, barbiturates, antidepressants, scopolamine, and monoamine-oxidase inhibitors, should be borne in mind when these other drugs are used concomitantly with or during the period of recovery from ATIVAN Injection (see CLINICAL PHARMACOLOGY and WARNINGS).
Information for Patients
Patients should be informed of the pharmacological effects of the drug, including sedation, relief of anxiety, and lack of recall, the duration of these effects (about 8 hours), and be apprised of the risks as well as the benefits of therapy.
The most important adverse clinical event caused by the use of ATIVAN Injection is respiratory depression (see WARNINGS).
Controlled Substance Class
Lorazepam is a controlled substance in Schedule IV.